ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004198
Recruitment Status : Completed
First Posted : May 21, 2004
Last Update Posted : January 17, 2018
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Genitope Corporation
Information provided by (Responsible Party):
Julie M Vose, MD, University of Nebraska

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2002
  Actual Study Completion Date : November 2003